The Meshima (Phellinus linteus) is a colossus of fungal medicine that commands both visual and pharmacological respect. With the appearance of a black, burnt, and cracked horse hoof clinging to the bark of wild mulberry trees, its slow, decades-long growth condenses an unparalleled defensive chemistry.
Clinically, it is arguably the medicinal mushroom with the most spectacular results in pure oncology. In South Korea, Phellinus linteus extracts are not sold as mere supplements; they are medically approved and prescribed in hospitals as immunotherapeutic cancer drugs. Its mechanism is not solely based on boosting defenses but on direct cytotoxic actions, such as inhibiting the blood vessels that feed tumors and forcing cellular suicide (apoptosis) in prostate and breast cancers. The dense, woody matrix of this mushroom guards an arsenal of polyphenols and Hispidin which, once liberated through double extraction, offer one of the most forceful botanical interventions modern science has validated.
